Korean J Fam Pract 2020; 10(6): 401-406  https://doi.org/10.21215/kjfp.2020.10.6.401
Depression in Primary Care
Jinyoung Shin*
Department of Family Medicine, Konkuk University School of Medicine, Seoul, Korea
Jinyoung Shin
Tel: +82-2-2030-7698, Fax: +82-2-2030-7749
E-mail: jyshin@kuh.ac.kr
ORCID: https://orcid.org/0000-0001-9558-1853
Received: April 17, 2020; Accepted: May 16, 2020; Published online: December 20, 2020.
© The Korean Academy of Family Medicine. All rights reserved.

This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0) which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Depression is a commonly encountered condition in the primary care that indicates low mood, loss of energy, sadness, loss of pleasure, sleep disorders or poor appetite, fatigue, and poor concentration. Of all the patients visiting the primary care, screening tests should be considered for the high-risk group and diagnosed using the Diagnostic and Statistical Manual of Mental Disorders (DSM-5). The purpose of treatment should be to assess and prevent the risk of suicides and administer medications, psychotherapy, and counseling to alleviate depression and restore daily life. Antidepressants are selected based on the comorbidities, side effects, and preferences of patients. These should be administered for a sufficient duration, followed by gradual reduction of the dosage and subsequent discontinuation of the drug. Counseling or psychotherapy may be considered for the treatment of depression. Primary care physicians should be skilled for screening, diagnosis, treatment, and counseling. Efficient treatment of depression in the primary care requires collaboration with the caregivers, psychiatrists, and nurse practitioners for assistance in its management.
Keywords: Depression; Primary Health Care; Diagnosis; Antidepressive Agent
  1. Ministry of Health and Welfare. Korea Health Statistics 2018: Korea National Health and Nutrition Examination Survey (KNHANES VII-3). Sejong: Ministry of Health and Welfare; 2019.
  2. Mitchell AJ, Yadegarfar M, Gill J, Stubbs B. Case finding and screening clinical utility of the Patient Health Questionnaire (PHQ-9 and PHQ-2) for depression in primary care: a diagnostic meta-analysis of 40 studies. BJPsych Open 2016; 2: 127-38.
    Pubmed KoreaMed CrossRef
  3. Vilagut G, Forero CG, Barbaglia G, Alonso J. Screening for depression in the general population with the Center for Epidemiologic Studies Depression (CES-D): a systematic review with meta-analysis. PLoS One 2016; 11: e0155431.
    Pubmed KoreaMed CrossRef
  4. Tarricone I, Stivanello E, Poggi F, Castorini V, Marseglia MV, Fantini MP, et al. Ethnic variation in the prevalence of depression and anxiety in primary care: a systematic review and meta-analysis. Psychiatry Res 2012; 195: 91-106.
    Pubmed CrossRef
  5. Howren MB, Lamkin DM, Suls J. Associations of depression with C-reactive protein, IL-1, and IL-6: a meta-analysis. Psychosom Med 2009; 71: 171-86.
    Pubmed CrossRef
  6. Craft TK, Devries AC. Vulnerability to stroke: implications of perinatal programming of the hypothalamic-pituitary-adrenal axis. Front Behav Neurosci 2009; 3: 54.
    Pubmed KoreaMed CrossRef
  7. Van der Kooy K, van Hout H, Marwijk H, Marten H, Stehouwer C, Beekman A. Depression and the risk for cardiovascular diseases: systematic review and meta analysis. Int J Geriatr Psychiatry 2007; 22: 613-26.
    Pubmed CrossRef
  8. Musselman DL, Evans DL, Nemeroff CB. The relationship of depression to cardiovascular disease: epidemiology, biology, and treatment. Arch Gen Psychiatry 1998; 55: 580-92.
    Pubmed CrossRef
  9. Shi S, Liu T, Liang J, Hu D, Yang B. Depression and risk of sudden cardiac death and arrhythmias: a meta-analysis. Psychosom Med 2017; 79: 153-61.
    Pubmed CrossRef
  10. Pan A, Sun Q, Okereke OI, Rexrode KM, Hu FB. Depression and risk of stroke morbidity and mortality: a meta-analysis and systematic review. JAMA 2011; 306: 1241-9.
    Pubmed KoreaMed CrossRef
  11. Fisch RZ. Masked depression: its interrelations with somatization, hypochondriasis and conversion. Int J Psychiatry Med 1987; 17: 367-79.
    Pubmed CrossRef
  12. Park HA. Major depressive disorder and other mood disorders. In: the Family Medicine Compilation Committee, editor. The textbook of family medicine. 5th ed. Seoul: The Korean Academy of Family Medicine; 2020. p. 1369-78.
  13. Ghosh RK, Ball S, Prasad V, Gupta A. Depression in heart failure: Intricate relationship, pathophysiology and most updated evidence of interventions from recent clinical studies. Int J Cardiol 2016; 224: 170-7.
    Pubmed CrossRef
  14. Park JH, Kim KW. A review of the epidemiology of depression in Korea. J Korean Med Assoc 2011; 54: 362-9.
  15. Maurer DM. Screening for depression. Am Fam Physician 2012; 85: 139-44.
  16. Whooley MA, Avins AL, Miranda J, Browner WS. Case-finding instruments for depression. Two questions are as good as many. J Gen Intern Med 1997; 12: 439-45.
    Pubmed KoreaMed CrossRef
  17. APA: DSM-5 development: depressive disorders [Internet]. Washington: American Psychiatric Association; 2013. [cited 2016 Dec 7].
  18. Yim HW, Jeong H, Jung YE, Wang HR, Kim SY. Management of depression and suicide. J Korean Med Assoc 2011; 54: 275-83.
  19. Bauer M, Severus E, Köhler S, Whybrow PC, Angst J, Möller HJ, et al. World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of unipolar depressive disorders. part 2: maintenance treatment of major depressive disorder-update 2015. World J Biol Psychiatry 2015; 16: 76-95.
    Pubmed CrossRef
  20. Wang HR, Bahk WM, Seo JS, Woo YS, Park YM, Jeong JH, et al. Korean Medication Algorithm for depressive disorder: comparisons with other treatment guidelines. Clin Psychopharmacol Neurosci 2017; 15: 199-209.
    Pubmed KoreaMed CrossRef
  21. Stuart MR, Lieberman JA III. The fifteen minute hour: therapeutic talk in primary care. 5th ed. London: Radcliffe Publishing; 2015.
  22. Kennedy SH, Lam RW, McIntyre RS, Tourjman SV, Bhat V, Blier P, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: section 3. Pharmacological treatments. Can J Psychiatry 2016; 61: 540-60.
    Pubmed KoreaMed CrossRef
  23. Institute for Clinical Systems Improvement (ICSI). Health care guideline: major depression in adults in primary care. 15th ed. Bloomington (MN): Institute for Clinical Systems Improvement; 2012. p. 32-51.

This Article